Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 29 | 30 | 29 | 375 | 29 |
| Operating Expenses | 16,483 | 14,915 | 14,692 | 14,483 | 14,369 |
| Operating Income | -16,454 | -14,885 | -14,663 | -14,108 | -14,340 |
| Interest Expense | 10 | 11 | N/A | N/A | N/A |
| Other Income | 579 | 2,481 | 143 | -4,234 | -1,367 |
| Pre-tax Income | -15,885 | -12,415 | -14,520 | -18,342 | -15,707 |
| Income Tax | 16 | 13 | N/A | N/A | N/A |
| Net Income Continuous | -15,901 | -12,428 | -14,593 | -18,342 | -15,707 |
| Net Income | $-15,901 | $-12,428 | $-14,593 | $-18,342 | $-15,707 |
| EPS Basic Total Ops | -0.17 | -0.14 | -0.17 | -0.21 | -0.19 |
| EPS Basic Continuous Ops | -0.17 | -0.14 | -0.17 | -0.21 | -0.19 |
| EPS Diluted Total Ops | -0.17 | -0.14 | -0.17 | -0.21 | -0.19 |
| EPS Diluted Continuous Ops | -0.17 | -0.14 | -0.17 | -0.21 | -0.19 |
| EBITDA(a) | $-15,490 | $-12,021 | $-14,308 | $-13,700 | $-13,937 |